Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Glioblastoma × Silybin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 2 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 15 Blood Specimen Collection 8 Bevacizumab 7 Temozolomide 6 Radiotherapy 5 Surgical Procedures, Operative 3 Restraint, Physical 3 Radiation 3 Palliative Care 3 Biopsy 3 Yoga 2 Standard of Care 2 Specimen Handling 2 Radiotherapy, Intensity-Modulated 2 Radiosurgery 2 Psychosocial Intervention 2 Perfusion Magnetic Resonance Imaging 2 Mind-Body Therapies 2 Lomustine 2 Gadolinium DTPA 2 Elasticity Imaging Techniques 2 Early Intervention, Educational 2 Drug Therapy 2 Diet Therapy 2 Dexamethasone 2 Chemotherapy, Adjuvant 2 Aminolevulinic Acid 2 tislelizumab 1 gallium Ga 68 dotatate 1 gadoteridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06964815 2025-12-02

STRONG

Istituto Oncologico Veneto IRCCS

Phase NA Recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡